Here, we demonstrate that increased DSS1 expression is correlated with chemo-resistance in sporadic breast cancers, which might be responsible for the worse prognosis of patients with high DSS1 levels, particularly with respect to relapse-free survival (RFS). Here, SEM1 is linked to breast cancer.